AML cells transduced with two different sgRNAs targeting TP53 largely rescued the proliferation defect induced by DCAF15 loss that was mediated by transduction with two different sgRNAs targeting DCAF15 (Fig. 2f). The gene discussed is TP53; the disease is acute myeloid leukemia.